Joon-Ki Jung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joon-Ki Jung has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Hongweon Lee
Biotechnology Process Engineering Center, Korean Research Institute of Bioscience and Biotechnology (KRIBB), 30 Yeongudanji-ro, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea.
6 shared publications - Jungoh Ahn
KRIBB: Korea Research Institute of Bioscience and Biotechnology
6 shared publications - Eun Gyo Lee
Bioprocess Engineering Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 30 Yeongudanjiro Ochang-eup, Chungju-si 28116, Korea
5 shared publications Jae-Bum Kim
3 shared publications- Yeon-Gu Kim
Biotherapeutics Translational Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea
3 shared publications Jung-Hoe Kim
Department of Biological Sciences, KAIST, Yuseong, Daejeon 305-701, Republic of Korea
2 shared publications
Latest Publications
- 1 May 2015
- Published by Elsevier in Process Biochemistry
- Vol. 50 (5) , 839-845
Radial scale-down of packed bed chromatography in a thin cylindrical tube for preparative media
- 1 May 2015
- Published by Elsevier in Process Biochemistry
- Vol. 50 (5) , 839-845
Radial scale-down of packed bed chromatography in a thin cylindrical tube for preparative media
- 23 February 2014
- Published by Springer Nature in Biotechnology Letters
- Vol. 36 (5) , 1125
Erratum to: Isolation and characterization of a novel ε-caprolactam-degrading microbe, Acinetobacter calcoaceticus, from industrial wastewater by chemostat-enrichment
- 23 February 2014
- Published by Springer Nature in Biotechnology Letters
- Vol. 36 (5) , 1125
Erratum to: Isolation and characterization of a novel ε-caprolactam-degrading microbe, Acinetobacter calcoaceticus, from industrial wastewater by chemostat-enrichment
- 24 August 2013
- Published by Springer Nature in Biotechnology Letters
- Vol. 35 (12) , 2069-2072
Isolation and characterization of a novel ε-caprolactam-degrading microbe, Acinetobacter calcoaceticus, from industrial wastewater by chemostat-enrichment
For the isolation of a ε-caprolactam-degrading microbe from wastewaters of a factory producing caprolactam, we applied a chemostat-enrichment technique with a selective medium containing caprolactam as sole source of carbon and nitrogen. This allowed for the isolation of a novel caprolactam-degrading microbe, identified as Acinetobacter calcoaceticus. The strain had a critical tolerance of 19 g caprolactam l−1 in minimal medium, which is higher than any previously reported caprolactam-degrading microbe. A. calcoaceticus also decreased the caprolactam content in medium by 65 % within 72 h despite the high caprolactam content (10 g l−1). This study highlights the potential use of A. calcoaceticus strain for the bioremediation of recalcitrant synthetic polymers, such as caprolactam.
- 24 August 2013
- Published by Springer Nature in Biotechnology Letters
- Vol. 35 (12) , 2069-2072
Isolation and characterization of a novel ε-caprolactam-degrading microbe, Acinetobacter calcoaceticus, from industrial wastewater by chemostat-enrichment
For the isolation of a ε-caprolactam-degrading microbe from wastewaters of a factory producing caprolactam, we applied a chemostat-enrichment technique with a selective medium containing caprolactam as sole source of carbon and nitrogen. This allowed for the isolation of a novel caprolactam-degrading microbe, identified as Acinetobacter calcoaceticus. The strain had a critical tolerance of 19 g caprolactam l−1 in minimal medium, which is higher than any previously reported caprolactam-degrading microbe. A. calcoaceticus also decreased the caprolactam content in medium by 65 % within 72 h despite the high caprolactam content (10 g l−1). This study highlights the potential use of A. calcoaceticus strain for the bioremediation of recalcitrant synthetic polymers, such as caprolactam.
- Open Access
- 15 January 2013
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 14 (1) , 1728-1739
Gamma-Aminobutyric Acid Production Using Immobilized Glutamate Decarboxylase Followed by Downstream Processing with Cation Exchange Chromatography
We have developed a gamma-aminobutyric acid (GABA) production technique using his-tag mediated immobilization of Escherichia coli-derived glutamate decarboxylase (GAD), an enzyme that catalyzes the conversion of glutamate to GABA. The GAD was obtained at 1.43 g/L from GAD-overexpressed E. coli fermentation and consisted of 59.7% monomer, 29.2% dimer and 2.3% tetramer with a 97.6% soluble form of the total GAD. The harvested GAD was immobilized to metal affinity gel with an immobilization yield of 92%. Based on an investigation of specific enzyme activity and reaction characteristics, glutamic acid (GA) was chosen over monosodium glutamate (MSG) as a substrate for immobilized GAD, resulting in conversion of 2.17 M GABA in a 1 L reactor within 100 min. The immobilized enzymes retained 58.1% of their initial activities after ten consecutive uses. By using cation exchange chromatography followed by enzymatic conversion, GABA was separated from the residual substrate and leached GAD. As a consequence, the glutamic acid was mostly removed with no detectable GAD, while 91.2% of GABA was yielded in the purification step.
- 15 January 2013
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 14 (1) , 1728-1739
Open AccessGamma-Aminobutyric Acid Production Using Immobilized Glutamate Decarboxylase Followed by Downstream Processing with Cation Exchange Chromatography
We have developed a gamma-aminobutyric acid (GABA) production technique using his-tag mediated immobilization of Escherichia coli-derived glutamate decarboxylase (GAD), an enzyme that catalyzes the conversion of glutamate to GABA. The GAD was obtained at 1.43 g/L from GAD-overexpressed E. coli fermentation and consisted of 59.7% monomer, 29.2% dimer and 2.3% tetramer with a 97.6% soluble form of the total GAD. The harvested GAD was immobilized to metal affinity gel with an immobilization yield of 92%. Based on an investigation of specific enzyme activity and reaction characteristics, glutamic acid (GA) was chosen over monosodium glutamate (MSG) as a substrate for immobilized GAD, resulting in conversion of 2.17 M GABA in a 1 L reactor within 100 min. The immobilized enzymes retained 58.1% of their initial activities after ten consecutive uses. By using cation exchange chromatography followed by enzymatic conversion, GABA was separated from the residual substrate and leached GAD. As a consequence, the glutamic acid was mostly removed with no detectable GAD, while 91.2% of GABA was yielded in the purification step.
- Open Access
- 15 May 2012
- Published by Springer Nature in BMC Biotechnology
- Vol. 12 (1) , 24
New cell line development for antibody-producing Chinese hamster ovary cells using split green fluorescent protein
Background: The establishment of high producer is an important issue in Chinese hamster ovary (CHO) cell culture considering increased heterogeneity by the random integration of a transfected foreign gene and the altered position of the integrated gene. Fluorescence-activated cell sorting (FACS)-based cell line development is an efficient strategy for the selection of CHO cells in high therapeutic protein production. Results: An internal ribosome entry site (IRES) was introduced for using two green fluorescence protein (GFP) fragments as a reporter to both antibody chains, the heavy chain and the light chain. The cells co-transfected with two GFP fragments showed the emission of green fluorescence by the reconstitution of split GFP. The FACS-sorted pool with GFP expression had a higher specific antibody productivity (q Ab) than that of the unsorted pool. The q Ab was highly correlated with the fluorescence intensity with a high correlation coefficient, evidenced from the analysis of median GFP and q Ab in individual selected clones. Conclusions: This study proved that the fragment complementation for split GFP could be an efficient indication for antibody production on the basis of high correlation of q Ab with reconstitution of GFP. Taken together, we developed an efficient FACS-based screening method for high antibody-producing CHO cells with the benefits of the split GFP system.
- 15 May 2012
- Published by Springer Nature in BMC Biotechnology
- Vol. 12 (1) , 24
Open AccessNew cell line development for antibody-producing Chinese hamster ovary cells using split green fluorescent protein
Background: The establishment of high producer is an important issue in Chinese hamster ovary (CHO) cell culture considering increased heterogeneity by the random integration of a transfected foreign gene and the altered position of the integrated gene. Fluorescence-activated cell sorting (FACS)-based cell line development is an efficient strategy for the selection of CHO cells in high therapeutic protein production. Results: An internal ribosome entry site (IRES) was introduced for using two green fluorescence protein (GFP) fragments as a reporter to both antibody chains, the heavy chain and the light chain. The cells co-transfected with two GFP fragments showed the emission of green fluorescence by the reconstitution of split GFP. The FACS-sorted pool with GFP expression had a higher specific antibody productivity (q Ab) than that of the unsorted pool. The q Ab was highly correlated with the fluorescence intensity with a high correlation coefficient, evidenced from the analysis of median GFP and q Ab in individual selected clones. Conclusions: This study proved that the fragment complementation for split GFP could be an efficient indication for antibody production on the basis of high correlation of q Ab with reconstitution of GFP. Taken together, we developed an efficient FACS-based screening method for high antibody-producing CHO cells with the benefits of the split GFP system.
- Open Access
- 28 December 2011
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 13 (1) , 358-368
Expression, Immobilization and Enzymatic Properties of Glutamate Decarboxylase Fused to a Cellulose-Binding Domain
Escherichia coli-derived glutamate decarboxylase (GAD), an enzyme that catalyzes the conversion of glutamic acid to gamma-aminobutyric acid (GABA), was fused to the cellulose-binding domain (CBD) and a linker of Trichoderma harzianum endoglucanase II. To prevent proteolysis of the fusion protein, the native linker was replaced with a S3N10 peptide known to be completely resistant to E. coli endopeptidase. The CBD-GAD expressed in E. coli was successfully immobilized on Avicel, a crystalline cellulose, with binding capacity of 33 ± 2 nmolCBD-GAD/gAvicel and the immobilized enzymes retained 60% of their initial activities after 10 uses. The results of this report provide a feasible alternative to produce GABA using immobilized GAD through fusion to CBD.
- 28 December 2011
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 13 (1) , 358-368
Open AccessExpression, Immobilization and Enzymatic Properties of Glutamate Decarboxylase Fused to a Cellulose-Binding Domain
Escherichia coli-derived glutamate decarboxylase (GAD), an enzyme that catalyzes the conversion of glutamic acid to gamma-aminobutyric acid (GABA), was fused to the cellulose-binding domain (CBD) and a linker of Trichoderma harzianum endoglucanase II. To prevent proteolysis of the fusion protein, the native linker was replaced with a S3N10 peptide known to be completely resistant to E. coli endopeptidase. The CBD-GAD expressed in E. coli was successfully immobilized on Avicel, a crystalline cellulose, with binding capacity of 33 ± 2 nmolCBD-GAD/gAvicel and the immobilized enzymes retained 60% of their initial activities after 10 uses. The results of this report provide a feasible alternative to produce GABA using immobilized GAD through fusion to CBD.
- 31 October 2011
- Published by Korean Society for Biotechnology and Bioengineering in KSBB Journal
- Vol. 26 (5) , 393-399
Evaluation of Nattokinase for Antithrombotic Effect and Pharmacological Efficacy by a Biological Test and Clinical Trial
- 31 October 2011
- Published by Korean Society for Biotechnology and Bioengineering in KSBB Journal
- Vol. 26 (5) , 393-399
Evaluation of Nattokinase for Antithrombotic Effect and Pharmacological Efficacy by a Biological Test and Clinical Trial
- 4 May 2009
- Published by Elsevier in Process Biochemistry
- Vol. 44 (8) , 899-905
High-level production of lycopene in metabolically engineered E. coli
- 4 May 2009
- Published by Elsevier in Process Biochemistry
- Vol. 44 (8) , 899-905
High-level production of lycopene in metabolically engineered E. coli
- 10 January 2009
- Published by Elsevier in Enzyme and Microbial Technology
- Vol. 44 (5) , 254-262
Efficient proteolytic cleavage by insertion of oligopeptide linkers and its application to production of recombinant human interleukin-6 in Escherichia coli
- 10 January 2009
- Published by Elsevier in Enzyme and Microbial Technology
- Vol. 44 (5) , 254-262
Efficient proteolytic cleavage by insertion of oligopeptide linkers and its application to production of recombinant human interleukin-6 in Escherichia coli
- 31 October 2008
- Published by Elsevier in Journal of Biotechnology
- Vol. 136, S334
Immobilization of a His-tagged lipase on a silica-coated magnetic nanoparticle coupled with metal affinity ligands
- 31 October 2008
- Published by Elsevier in Journal of Biotechnology
- Vol. 136, S334
Immobilization of a His-tagged lipase on a silica-coated magnetic nanoparticle coupled with metal affinity ligands